Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions

2013 ◽  
Vol 9 (6) ◽  
pp. 721-729 ◽  
Author(s):  
Alexandre Abizaid ◽  
John A Ormiston ◽  
Jean Fajadet ◽  
Laura Mauri ◽  
Joachim Schofer ◽  
...  
Keyword(s):  
Coronary Artery ◽  
De Novo ◽  
Coronary Stent ◽  
Coronary Artery Lesions ◽  
Native Coronary Artery

scholarly journals First-in-Man 1-Year Clinical Outcomes of the Catania Coronary Stent System With Nanothin Polyzene-F in De Novo Native Coronary Artery Lesions

2009 ◽  
Vol 2 (3) ◽  
pp. 197-204 ◽  
Author(s):  
Corrado Tamburino ◽  
Alessio La Manna ◽  
Maria Elena Di Salvo ◽  
Giorgio Sacchetta ◽  
Davide Capodanno ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Clinical Outcomes ◽  
De Novo ◽  
Coronary Stent ◽  
Coronary Artery Lesions ◽  
Native Coronary Artery ◽  
Stent System

scholarly journals 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions

2009 ◽  
Vol 2 (12) ◽  
pp. 1190-1198 ◽  
Author(s):  
Scot Garg ◽  
Patrick Serruys ◽  
Yoshinobu Onuma ◽  
Cécile Dorange ◽  
Susan Veldhof ◽  
...  
Keyword(s):  
Coronary Artery ◽  
De Novo ◽  
Coronary Stent ◽  
Coronary Artery Lesions ◽  
Stent System
Sign in / Sign up

Export Citation Format

Share Document